Bradley Mark J. Zoetis Inc. Transaction History

Bradley Mark J.

$99.3 Million
Q2 2023

A detailed history of Bradley Mark J. transactions in Zoetis Inc. stock. As of the latest transaction made, Bradley Mark J. holds 15,850 shares of ZTS stock, worth $2.61 Million. This represents 2.75% of its overall portfolio holdings.

Number of Shares

15,850

Previous 23,360 32.15%

Holding current value

$2.61 Million

Previous $3.89 Million 29.81%

% of portfolio

2.75%

Previous 2.82%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$160.94 - $186.23 $1.21 Million - $1.4 Million	-7,510 Reduced 32.15%	15,850 $2.73 Million
Q1 2023 May 15, 2023	BUY	$145.48 - $175.02 $598,650 - $720,207	4,115 Added 21.38%	23,360 $3.89 Million
Q4 2022 Feb 15, 2023	BUY	$131.14 - $157.47 $275,394 - $330,687	2,100 Added 12.25%	19,245 $2.82 Million
Q3 2022 Nov 15, 2022	BUY	$148.29 - $182.55 $119,373 - $146,952	805 Added 4.93%	17,145 $2.54 Million
Q2 2022 Jul 15, 2022	BUY	$155.97 - $200.09 $62,388 - $80,036	400 Added 2.51%	16,340 $2.81 Million
Q1 2022 May 12, 2022	SELL	$181.39 - $234.03 $18,139 - $23,403	-100 Reduced 0.62%	15,940 $3.01 Million
Q4 2021 Mar 07, 2022	SELL	$193.69 - $247.03 $48,422 - $61,757	-250 Reduced 1.53%	16,040 $3.91 Million
Q3 2021 Nov 08, 2021	SELL	$189.29 - $209.69 $45,429 - $50,325	-240 Reduced 1.45%	16,290 $3.16 Million
Q2 2021 Jul 22, 2021	SELL	$155.9 - $187.99 $77,170 - $93,055	-495 Reduced 2.91%	16,530 $3.08 Million
Q1 2021 May 13, 2021	BUY	$144.0 - $169.39 $90,000 - $105,868	625 Added 3.81%	17,025 $2.68 Million
Q4 2020 Feb 18, 2021	BUY	$157.07 - $174.35 $2.58 Million - $2.86 Million	16,400 New	16,400 $2.72 Million

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Mark J., based on Form 13F filings with the SEC.

News

Stay updated on Bradley Mark J. with notifications on news.

Account